Dana-Farber Cancer Institute: New Research Uncovers How Cancers With Common Gene Mutation Develop Resistance to Targeted Drugs
June 24, 2021
June 24, 2021
BOSTON, June 24 -- The Dana-Farber Cancer Institute issued the following news release on June 23, 2021:
A new study by Dana-Farber Cancer Institute researchers has given scientists their first look at the genomic landscape of tumors that have grown resistant to drugs targeting the abnormal KRASG12C protein. Their work shows that, far from adopting a common route to becoming resistant, the cells take a strikingly diverse set of avenues, often several at a time.
The findi . . .
A new study by Dana-Farber Cancer Institute researchers has given scientists their first look at the genomic landscape of tumors that have grown resistant to drugs targeting the abnormal KRASG12C protein. Their work shows that, far from adopting a common route to becoming resistant, the cells take a strikingly diverse set of avenues, often several at a time.
The findi . . .